LONDON, October 22 /PRNewswire/ -- Gandi.net, the largest ICANN-accredited registrar in France, announces its expansion into the UK domain name and virtualised hosting market.

DUBAI, United Arab Emirates, October 22 /PRNewswire/ --

South Korean-based SK Engineering and Construction (SKEC) is using Quadrem solutions to manage sourcing and procurement communications with an international community of 5,000 suppliers. Approximately 300 to 400 tenders are expected to be issued by SKEC to support a gas train project it's undertaking in the Middle East for a national petroleum company.

We chose Quadrem to handle Web-based sourcing and procurement for this USD $2 billion project because we must provide excellent management of worldwide suppliers, said Mr. Oh-Young LEE, Project Procurement Chief Manager of the Fourth Gas Train Project Team, SKEC.

BEIJING, October 22 /PRNewswire/ --

- Company sets new goals and greater expectations for environmental and social compliance, transparency and accountability

Today, Wal-Mart Stores, Inc. (NYSE: WMT) took the next step in its sustainability journey by hosting an unprecedented gathering of more than 1,000 leading suppliers, Chinese officials and NGOs in Beijing, China. The company outlined a series of aggressive goals and expectations to build a more environmentally and socially responsible global supply chain.

CAMBRIDGE, England, October 22 /PRNewswire/ --

- Three in Five Patients Feel Depressed or Anxious as a Result of Their Pain

LEEDS, England, October 22 /PRNewswire/ --

- Immediate Steps are Required in the Meantime to Protect Patients

New research presented today shows that the information given to the volunteers of the disastrous Northwick Park Elephant Man trial would not have passed a 'readability' test. The research, presented at the international meeting of the Drug Information Association today, highlights an immediate need for all information provided to volunteers in clinical trials to be 'User Tested' before future trial protocols can be approved.

SARASOTA, Florida, October 21 /PRNewswire/ --

A team of world-renowned scientists today announced the launch of Archer Pharmaceuticals, Inc., a new company that will use modern technologies for the identification of novel treatments for Alzheimer's disease.

Archer Pharmaceuticals, Inc., led by Chief Executive Officer Michael Mullan, M.B.B.S., Ph.D. and Chief Technical Officer Fiona Crawford, Ph.D., was created based on the groundbreaking research that their team has been conducting in Florida for the past five years.